Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Empirical micafungin treatment doesn't improve survival

medicalxpress.com October 8, 2016

Empirical treatment with micafungin seems not to increase invasive fungal infection (IFI)-free survival at 28 days for patients with intensive care unit (ICU)-acquired sepsis with Candida colonization.

infection research sepsis study treatment

Impacts of Initial ICU Driving Pressure on Outcomes in Acute Hypoxemic Respiratory Failure

Effects of Surgery on Hemodynamics and Postoperative Delirium in Stanford Type A Aortic Dissection

Implementing a Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy Team Reduces Length of Stay and Hospital Costs

Predictors of Weaning Failure in Ventilated ICU Patients

Fluid, Electrolyte and Acid-Base Disorders

Improving Critical Care Survivorship: A Guide to Prevention, Recovery, and Reintegration

Management of Dysregulated Immune Response in the Critically Ill

Where Night Is Day: The World of the ICU

ECMO, An Issue of Critical Care Clinics

Abdominal Sepsis: A Multidisciplinary Approach

The 2018-2023 World Outlook for Sepsis Drugs

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient

Severe Trauma and Sepsis: Organ Damage and Tissue Repair

Moderate and Deep Sedation in Clinical Practice

Basics of Mechanical Ventilation